Galon J, Mlecnik B, Marliot F, et al (2016)Validation of the immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: results of a worldwide consortium-based analysis of 1,336 patients. J Clin Oncol 34(suppl):abstr 3500

F. Bibeau

Galon J, Mlecnik B, Marliot F, et al (2016)Validation of the immunoscore (IM) as a prognostic marker in stage I/II/III colon cancer: results of a worldwide consortium-based analysis of 1,336 patients. J Clin Oncol 34(suppl):abstr 3500

2016

F. Bibeau

Background Mounting evidence indicates an enhanced lymphocytic reaction as an informative prognostic indicator in colon cancer (CC). The IM methodology has been defined to quantify the in situ immune infiltrate.

Keywords:

Colorectal cancer
Immune system
Cancer research
Pathology
Medicine
clin oncol
Colorectal surgery
stage ii
immune infiltrate
stage i ii
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations